Lotensin HCT (benazepril hydrochloride and hydrochlorothiazide, USP)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- May 2008
|The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.|
- Drug Interactions
- Unknown Frequency
- Small bowel angioedema, anaphylactoid reactions, hyperkalemia, agranulocytosis, neutropenia.
Label approved 05/29/2008 is not available on Drugs@FDA